Clinical trial
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer…
NCT00002993 · Gynecologic Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00002993 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus |
| Official title | Evaluation of Mitomycin, Doxorubicin and Cisplatin in the Treatment of Recurrent or Advanced Uterine Sarcomas |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | cisplatin, doxorubicin hydrochloride, mitomycin C |
| Enrollment | 30 |
| Start date | Aug 1, 1997 |
| Primary completion | Jan 1, 2000 |
| First posted | Sep 3, 2004 |
| Last update posted | Jul 9, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: